Search Within

Alexandra Miller

Formats
  1. Meeting Abstract (44)
  2. Journal Article (21)
  3. Review (4)
  4. Editorial (3)
  5. Research Letter (2)
Groups
  1. GSK Faculty (45)
  2. Tow Center for Developmental Oncology (TCDO) (44)
  3. Human Oncology and Pathogenesis Program (43)
  4. Department of Pathology and Laboratory Medicine (42)
  5. Graduate Medical Education (31)
  6. Pediatrics, Department of (24)

More Groups

People
  1. Ingo Mellinghoff (37)
  2. Tejus Bale (27)
  3. Elena Pentsova (20)
  4. Maria Arcila (20)
  5. Matthias Karajannis (20)
  6. Michael Berger (18)

More People

Years
  1. 2024 (12)
  2. 2023 (17)
  3. 2022 (12)
  4. 2021 (7)
  5. 2020 (12)
  6. 2019 (8)

More Years

Publications
  1. Neuro-Oncology (30)
  2. Neurology (8)
  3. Journal of Neuropathology and Experimental Neurology (4)
  4. Journal of Clinical Oncology (3)
  5. Neuro-Oncology Advances (3)
  6. Acta Neuropathologica Communications (2)

More Publications

Publishers
  1. Oxford University Press (38)
  2. Lippincott Williams & Wilkins (8)
  3. American Society of Clinical Oncology (4)
  4. Elsevier Science, Inc. (4)
  5. American Association for Cancer Research (3)
  6. BioMed Central Ltd. (2)

More Publishers

Results (74)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high-grade glioma
    Meeting Abstract

    Miller, A. M.; Nandakumar, S.; Holle, B. M.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A. J.; Rafailov, J.; Campos, C.; Brannon, A. R.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Real-world experience with circulating tumor DNA in cerebrospinal fluid in patients with central nervous system tumors
    Meeting Abstract

    Hickman, R.; Miller, A. M.; Holle, B. M.; Jee, J.; Liu, S. Y.; Ross, D.; Yu, H.; Riely, G. J.; Ombres, C.; Gerwitz, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Prognostic implications of cerebrospinal fluid circulating tumor DNA (CSF ctDNA) following radiation therapy in patients with leptomeningeal metastasis: Analysis of a randomized phase II trial
    Meeting Abstract

    Goglia, A. G.; Yang, J. T.; Kratochvil, L. B.; Yerramilli, D.; Higginson, D. S.; Miller, A.; Berger, M.; Powell, S. N.; Boire, A.; Wijetunga, N. A.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (CTDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high-grade glioma
    Meeting Abstract

    Holle, B. M.; Nandakumar, S.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A. J.; Rafailov, J.; Campos, C.; Reiner, A. S.; Young, R.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • The landscape of gliomas in children, adolescents and young adults reveals insights on gliomagenesis: A Canadian Adolescents and Young Adults Neuro-Oncology Network (CANON) study
    Meeting Abstract

    Bennett, J.; Levine, A.; Nobre, L.; Negm, L.; Chung, J.; Fang, K.; Johnson, M.; Komosa, M.; Krumholtz, S.; Nunes, N. M.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Minimally-invasive molecular diagnosis of diffuse leptomeningeal glioneuronal tumor (DLGNT) using cerebrospinal fluid cell-free DNA sequencing in pediatric and young adult patients
    Meeting Abstract

    Larsen, A. M. G.; Hill, K.; Hickman, R.; Bale, T. A.; Holle, B.; Mellinghoff, I.; Dunkel, I.; Souweidane, M.; Greenfield, J.; Sait, S. F.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Minimally-invasive molecular diagnosis of infiltrating brainstem gliomas through cerebrospinal fluid cell-free DNA sequencing
    Meeting Abstract

    Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B. M.; Ucpinar, B. A.; Alano, T.; Doe-Tetteh, S.; DiNapoli, S.; Riviere-Cazaux, C.; Burns, T. C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors
    Journal Article

    Hickman, R. A.; Miller, A. M.; Holle, B. M.; Jee, J.; Liu, S. Y.; Ross, D.; Yu, H.; Riely, G. J.; Ombres, C.; Gewirtz, A. N.; more...
    Acta Neuropathologica Communications (2024)

    Fulltext@MSK | Save
  • Systematic review of cerebrospinal fluid biomarker discovery in neuro-oncology: A roadmap to standardization and clinical application
    Review

    Mikolajewicz, N.; Yee, P. P.; Bhanja, D.; Trifoi, M.; Miller, A. M.; Metellus, P.; Bagley, S. J.; Balaj, L.; de Macedo Filho, L. J. M.; Zacharia, B. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world use of hypofractionated radiotherapy for primary CNS tumors in the elderly, and implications on Medicare spending
    Journal Article

    Tringale, K. R.; Lin, A.; Miller, A. M.; Khan, A.; Chen, L.; Zinovoy, M.; Yamada, Y.; Yu, Y.; Pike, L. R. G.; Imber, B. S.
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save